Cigna is launching a health tracking feature through compatible fitness devices on its MyCigna platform. Teaming up with Virgin Pulse, the initiative allows users to monitor mental, physical, and social health progress. Initial rollout begins on January 1, 2024, targeting select employer-covered customers. The service’s expansion is planned over time. Cigna’s Q2 sales saw a 7% rise, driven by its healthcare division and Evernorth Health Services. The company introduced Copay Assurance and ClearCareRx in April.
Cigna, having recently disclosed its earnings, plans to leverage fitness data to connect users with relevant health programs.
Cigna Healthcare is set to unveil a fresh feature on its MyCigna benefits platform in the coming year, enabling users to monitor their mental, physical, and social health progress by syncing with compatible fitness devices.
Partnering with the AI-driven technology provider Virgin Pulse, Cigna’s health benefits division aims to offer this service. The initial implementation is scheduled for January 1, 2024, targeting select Cigna customers who receive coverage through their employers, with plans to gradually expand the service.
Participants will be able to utilize devices like Apple Watches and other compatible fitness gadgets to log daily measurements such as weight, sleep duration, and exercise minutes. Moreover, they can share their activities with other platform users.
By analyzing users’ logged data, preferences, and claims history, MyCigna can connect them to other applicable programs available through Cigna Healthcare benefits. This includes services like pre-diabetes management and behavioral health assistance.
Heather Dlugolenski, Senior Vice President of Commercial Strategy and Solutions at Cigna Healthcare, stated, “Digital health programs enhance well-being for individuals and communities alike.”
Cigna’s 2Q Sales Boosted by Healthcare Segment
On August 3, Cigna Group reported adjusted second-quarter sales of $48.6 billion, reflecting a 7% increase compared to the same period last year. Strong contributions from both Cigna Healthcare and Evernorth Health Services, its other health services unit, offset the revenue loss from divestitures. These included the sale of life, accident, and supplemental benefits businesses to Chubb INA Holdings in July 2022 across six countries.
Cigna Healthcare’s adjusted revenue for the quarter surged by 12% to $12.7 billion, attributed to customer growth and premium rate adjustments.
However, Cigna Group reported a decline in net income for the quarter, reaching $1.46 billion, down from $1.56 billion in the second quarter of 2022. This dip was due to the absence of income from the divested businesses.
This announcement follows the launches last April of the Copay Assurance plan and ClearCareRx, both under Evernorth’s pharmacy benefits manager Express Scripts.
The Copay Assurance plan aims to reduce customers’ out-of-pocket expenses for prescription drugs by setting a maximum cost, including $5 for generics and specialty generics, $25 for preferred brand drugs, and $45 for preferred specialty brand drugs.
Features of the ClearCareRx program include enabling employer, health plan, and government employer customers to pay the same amount that Express Scripts pays pharmacies for prescriptions, along with receiving 100% of the drug rebates negotiated by Express Scripts with pharmaceutical companies.